Development of a Chatbot-supported Personalized Exercise Program for Older Adults and Evaluation of Its Effects on Cognitive Functions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorDokuz Eylul University

About this trial

The purpose of this study is to develop an artificial intelligence-based chatbot application to support exercise behavior in individuals aged 60 and over who do not regularly exercise, and to evaluate its effectiveness. In addition, the study aims to examine the effects of changes in exercise habits on the cognitive (mental) functions of older adults.

In this study, the impact of a chatbot-supported personalized exercise program on cognitive functions in older individuals will be evaluated. A total of 90 participants is planned for inclusion in this study.

If you agree to participate in this study, depending on the group you are assigned to, you may receive:

* An artificial intelligence-based chatbot program, along with educational materials about the importance of exercise, or * Only educational materials (brochures) prepared by the researchers about the importance of exercise.

At the beginning of the study, you will be asked to complete a data collection form. The same form will also be administered at week 12 and week 24.

This form will include:

* Basic information such as your age and gender, * Questions about your exercise habits, * A brief test to assess your cognitive (mental) functions, * Questions evaluating your level of physical activity. The study duration is 24 weeks, including 12 weeks of intervention and 12 weeks of follow-up.

Eligibility criteria

Qualifiers

Aged 65 years and older

Normal or mildly impaired cognitive status

Medical condition that does not prevent participation in physical activity

Ability to use a smartphone or tablet (for chatbot access)

Disqualifiers

Moderate to severe dementia

Severe depression or serious psychiatric disorders

Acute cardiovascular risk

Communication difficulties due to significant hearing or visual impairment

Trial design

Treatments tested in this trial

  • Artificial intelligence-supported chatbot

Treatment groups

90 Participants
are divided into 2 treatment groups

Sponsors and collaborators